Periodical (Journal)

  1. PSIthority
  2. Library
  3. Periodicals
ISSN  :   2589-0042 ( Online )   Active

iScience

Aim & Scope
Science has many big remaining questions. To address them, we will need to work collaboratively and across disciplines. The goal of iScience is to help fuel that type of interdisciplinary thinking. iScience is a new open-access journal from Cell Press that provides a platform for original research in the life, physical, and earth sciences. The primary criterion for publication in iScience is a significant contribution to a relevant field combined with robust results and underlying methodology. The advances appearing in iScience include both fundamental and applied investigations across this interdisciplinary range of topic areas. To support transparency in scientific investigation, we are happy to consider replication studies and papers that describe negative results. We know you want your work to be published quickly and to be widely visible within your community and beyond. With the strong international reputation of Cell Press behind it, publication in iScience will help your work garner the attention and recognition it merits. Like all Cell Press journals, iScience prioritizes rapid publication. Our editorial team pays special attention to high-quality author service and to efficient, clear-cut decisions based on the information available within the manuscript. iScience taps into the expertise across Cell Press journals and selected partners to inform our editorial decisions and help publish your science in a timely and seamless way. [1]

Go to Website

2022 - VOLUME 25, ISSUE 6
9 RESULTS in 14 msec
SARS-CoV-2-related pangolin coronavirus exhibits similar infection characteristics to SARS-CoV-2 and direct contact transmissibility in hamsters.

Z Guo , C Zhang , C Zhang , ... , Y Gao

iScience , 2022 - VOLUME 25, ISSUE 6 , p 104350.

 
0 0
Pearson's patterns correlational of clinical risks at admissions with hospitalization outcomes during initial COVID-19 outbreak.

J Li , X Long , Q Zhang , ... , Z Lin

iScience , 2022 - VOLUME 25, ISSUE 6 , p 104415.

 
0 0
Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants.

Y Li , Q Fan , B Zhou , ... , Z Zhang

iScience , 2022 - VOLUME 25, ISSUE 6 , p 104431.

 
0 0
The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro.

L Markus J , K Ritesh , Z Bryan , ... , B Charles R

iScience , 2022 - VOLUME 25, ISSUE 6 , p 104445.

 
0 0
Modeling explains prolonged SARS-CoV-2 nasal shedding relative to lung shedding in remdesivir treated rhesus macaques.

A Goyal , ER Duke , EF Cardozo-Ojeda , JT Schiffer

iScience , 2022 - VOLUME 25, ISSUE 6 , p 104448.

 
0 0
COH04S1 and Beta Sequence Modified Vaccine Protect Hamsters From SARS-CoV-2 Variants.

F Wussow , M Kha , K Faircloth , ... , DJ Diamond

iScience , 2022 - VOLUME 25, ISSUE 6 , p 104457.

 
0 0
Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection.

D Sheerin , Abhimanyu , N Peton , ... , AK Coussens

iScience , 2022 - VOLUME 25, ISSUE 6 , p 104464.

 
0 0
Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes Omicron.

HK Lee , J Go , H Sung , ... , JW Huh

iScience , 2022 - VOLUME 25, ISSUE 6 , p 104473.

 
0 0
Early detection and improved genomic surveillance of SARS-CoV-2 variants from deep sequencing data.

D Ramazzotti , D Maspero , F Angaroni , ... , A Graudenzi

iScience , 2022 - VOLUME 25, ISSUE 6 , p 104487.

 
0 0
 
8 RESULTS in 0 msec